Introduction
The liver plays vital role in the biotransformation of drugs and toxins. 1 In view of the function of the liver, in the biotransformation of drugs and toxins, liver cells which include Kupffer, hepatic stellate, endothelial and parenchymal cells are major target of oxidative radicals produced by drugs and toxins. 2, 3 Oxidative stress has been shown to be an essential originating factor in the pathogenesis of drug-induced hepatic damage. 4, 5 The over-production of oxidative radicals is toxic to hepatocytes and initiates reactive oxygen species (ROS)-mediated cascade causing hepatocyte death, and leading to acute or chronic hepatic damage. 6, 7 The use of Efavirenz (EFV) a member of the non-nucleoside reverse transcriptase inhibitors (NNRTIs) has dramatically reduced human immunodeficiency virus (HIV)-related morbidity and mortality in the world. 8 However, studies have associated the use of EFV with hepatic damage which is a frequent class problem of the non-NNRTIs. 9, 10 The molecular pathogenesis of this effect is poorly understood, but recent reports have highlighted features of mitochondrial dysfunction in hepatic cells exposed to clinically relevant concentrations of EFV. 11 Also, recent studies have demonstrated endoplasmic reticulum stress responses involving mitochondrial dysfunction and oxidative stress in human hepatic cell lines. 12 N-acetylcysteine (NAC) is the acetylated derivative of the amino acid L-cysteine. It is frequently employed as a source of sulfhydryl groups to cells as an acetylated precursor of reduced GSH. It is an antioxidant that interacts directly with reactive oxygen and nitrogen species and up-regulate endogenous GSH status, thereby preventing oxidative stress-induced alterations in biomolecules. 13 Furthermore, in experimental animal model and clinical studies, NAC showed ameliorative effect on drug-induced acute liver injury and has been clinically adopted for the treatment of acetaminophen associated hepatotoxicity. 14, 15 Moreover, animal and human studies of NAC suggest that it is a very safe as an effective tool for the treatment of many diseases considered to be mediated by oxidative radical and it has been used therapeutically in several disorders related to oxidative stress. 16 Vitamin E is the major lipid-soluble and potent chainbreaking antioxidant that inhibits the production of oxidative radicals when fat undergoes oxidation and during the propagation of free radical reactions. 17 It is primarily located in cell and organelle membranes where it can exert its protective effect. It acts as the first line of defence against lipid peroxidation, by protecting polyunsaturated fatty acids present in membrane phospholipids and in plasma lipoproteins from free radical attack. 18, 19 It is the only major lipid-soluble, chain breaking antioxidant found in plasma, red cells and tissues, allowing it to protect the integrity of lipid structures, mainly membranes. 20 In addition, previous studies have demonstrated the potential of vitamin E in the amelioration of drug-induced hepatotoxicity in animal model . 21, 22 Vitamin C is a six-carbon compound structurally related to glucose. It consists of two inter-convertible compounds: L-ascorbic acid, which is a strong reducing agent, and its oxidized derivative, L-dehydroascorbic acid. 23 It is a water-soluble antioxidant with diverse biological functions. Its actions include acting as a cofactor for the enzymes involved in collagen hydroxylation, biosynthesis of carnitine and norepinephrine, tyrosine metabolism and peptide hormone amidation. 24 Its antioxidant property includes inhibition of lipid peroxidation, oxidative cell damage and stimulatory effects on other antioxidants especially vitamin E. 25, 26 Furthermore, vitamin C has shown ameliorative effect on drug-induced hepatotoxity as shown in in-vivo animal studies. 27, 28 The present study was therefore designed to evaluate the effects of NAC, vitamins C and E on efavirenz-induced hepatotoxicity in albino rats.
Materials and Methods

Drugs and Chemicals
The vitamin E used for this study was manufactured by strides pharmaceuticals India while vitamin C was manufactured by Emzor pharmaceuticals industries Lagos, Nigeria. Efavirenz was manufactured by Miland laboratory, India. The present study used 20 mg/kg/day of NAC, 50 mg/kg/day of vitamin C and 50 mg/kg/day of vitamin E 29, 30 and 60 mg/kg/ day of EFV. NAC was dissolved normal saline, vitamin C was dissolved in water while arachis oil was used as the vehicle for vitamin E and EFV .
Grouping of Rats and Drug Administration
Fifty five albino rats were randomized into six groups A-E. Groups A, B, D contained five rats each while group C and E contained twenty rats each which were further divided into four sub-groups of five rats each. The rats in group A served as placebo control whereas group B served as the solvent control and were administered with normal saline and arachis oil respectively. The rats in group C were orally administered with NAC (20 mg/kg/day), vitamin C (50 mg/kg/day), vitamin E (50 mg/kg/day) and a combination of vitamins C+ E respectively. The rats in group D were orally administered with 60 mg/kg/day of EFV. The rats in groups E were orally pretreated with NAC, vitamin C, vitamin E, and combined doses of vitamins C+E prior to the administration of EFV for 15 days respectively.
Collection of Samples and Biochemical Analysis
After the termination of drug administration on day 15, the rats were fasted overnight and sacrificed under diethyl ether. The blood was collected via cardiac puncture; serum was extracted and evaluated for alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, gamma glutamyl transferase conjugated and total bilirubin using Randox Diagnostic kits (Randox Laboratories Ltd., Crumlin, U.K.). Liver was excised, weighed and washed in cold 1.15% KCL solution, then homogenized and centrifuged. The supernatant was decanted and used for the evaluation of oxidative stress indices. Glutathione peroxidase (GPX) activity was evaluated as reported by Rotruck et al., 1973 31 SOD activity was determined by the method of Sun and Zigma (1978) 32 while CAT activity was measured according to Sinha et al., 1972 . 33 Reduced Glutathione was analyzed according as described by Sedlak and Lindsay (1968) 34 while malondialdehyde (MDA) was measured using the method of Buege and Aust (1978) . 35 
Histological Examination of the Liver
The histological examination of the liver was performed in Anatomical Pathology Department of University of Port Harcourt Teaching Hospital, Choba, Rivers State, Nigeria. The liver tissue was excised and rinsed in normal saline. Liver sections were taken and processed and embedded in paraffin.
Liver tissues were then processed into sections 4-5 μm thick, stained with Hematoxylin and Eosin and observed under a light microscope for any morphological changes.
Statistical Analysis
Results are expressed as mean ± SD. Differences among the experimental groups were identified by one-way analysis of variance and Tukey's multiple comparison test and a p < 0.05 was considered significant.
Results
Effects on Body, Liver Weights and Liver Function Parameters
The administration of NAC, vitamins C and E for 15 days did not produce significant (p > 0.05) effects on serum levels of AST, ALT, ALP, GGT, LDH, TB and CB when compared to control ( Table 2 and 3) .On the other hand, the above parameters were significantly (p < 0.05) increased in rats administered with 60mg/kg/day of EFV for 15 days with no significant (p > 0.05) effects on the body and liver weights in comparison to control (Table 1-3) . However, rats pretreated with individual doses of NAC, vitamins C and E showed significant (p < 0.05) reductions in the serum levels of AST, ALT, ALP, GGT, LDH, CB and TB when compared to EFV-treated rats (Table 2 and 3) . Furthermore, a combination of vitamins C and E produced most and significant (p < 0.05) reductions in the serum levels of AST, ALT, ALP, GGT, LDH, CB and TB when compared to their individual doses, but effects did not differ significantly (p < 0.05) from pretreatment with NAC (Table 1and 2). Furthermore, treatment with NAC, Vit C and E did not produce significant (p < 0.05) effects on liver levels of AST, ALT, ALP, GGT, and LDH in comparison to control. On the contrary, these parameters were significantly (p < 0.05) increased in EFV-treated rats in comparison to control (Table 1 and 2) . However, the liver levels of AST, ALT, ALP, GGT, and LDH were decreased significantly (p < 0.05) in rats pretreated with NAC, vitamins C and E prior to treatment with EFV. The observed decreases in these parameters were most and significant (p < 0.05) in rats pretreated with combined doses of vitamins C and E when compared to their individual doses. However, decreases observed in these parameters in rats pretreated with combined doses of vitamins C and E did not differ (p > 0.05) when compared to NAC pretreated rats (Table 2 and 3) .
Effects on Oxidative Stress Indices and Liver Histology
The administration of NAC, vitamins C and E did not produce significant (p > 0.05) effects on the liver levels of SOD, CAT, GSH, GPX and MDA when compared to control. In contrast, liver levels of SOD, CAT, GSH and GPX were decreased significantly (p < 0.05) whereas MDA levels were increased significantly (p < 0.05) in rats treated with EFV when compared to control (Table 4) . However, rats pretreated with NAC, vitamin C, and E prior to treatment with EFV showed significant (p < 0.05) increases in SOD, CAT, GSH and GPX levels whereas MDA levels were decreased significantly (p < 0.05) when compared to EFV-treated rats. Interestingly, pretreatment with a combination of vitamins C and E produced the most and significant (p < 0.05) effects on SOD, CAT,
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Antioxidants ameliorate efavirenz-induced liver damage Table 3 . Effects of n-acetylcysteine, vitamins C and E on liver levels of biomarkers of liver function in efavirenz-treated albino rats GSH, GPX and MDA levels when compared to individual doses. However effects observed in rats pretreated with combined doses of vitamins C and E were not significantly (p > 0.05) different when compared to pretreatment with NAC (Table 4) . Furthermore, microscopic examination of the H and E stained sections of the liver of control rat and rats administered with NAC, vitamins C and E showed normal histology (Fig 1A-E) . Liver of rats treated with EFV shows necrosis of hepatocyte (Fig 1.F) . However, the liver of rats pretreated with NAC, vitamins C and E and combined doses of vitamin C and E showed normal histology (Fig 1. G-J) 
Discussion
Oxidative stress, a consequence of free radicals' generation is a common mechanism underlying hepatotoxicity caused by drugs and toxicants. 36 Antioxidants are chemical agents that scavenge, neutralize and mop-up free radicals, thereby preventing oxidative stress. 37 Therefore, the present study evaluated the benefits of NAC, vitamins C and E on EFV-induced liver toxicity in albino rats. In the current study, treatment with NAC, vitamins C and E did not produce significant effects on AST, ALT, ALP, GGT, LDH, CB, TB, SOD, GSH, and CAT levels. These observations are in conjunction with previous reports. 38, 39 This study did not observe significant effects on the body and liver weights in EFV-treated rats, however; levels of AST, ALT, ALP, GGT, LDH, CT, TB and MDA were elevated whereas SOD, GSH, CAT and GPX levels were reduced significantly. In addition, alterations in hepatic morphology were observed in EFV-treated rats. These finding are consistent with previous reports. [40] [41] [42] AST and ALT are enzymes involved in the transfer of amino groups of aspartate and alanine to ketoglutaric acid. 43 AST, ALT and ALP are present in the liver but, ALT is primarily located in the liver, and thus is a more specific marker of hepatocellular cell injury. [44] [45] [46] Bilirubin is produced by the normal breakdown of pigment-containing proteins, especially haemoglobin from senescent red blood cells and myoglobin from muscle breakdown. 47 AST, ALT, ALP, GGT, LDH and bilirubin are clinically used as fundamental indices for the assemement of the functionality of the liver. Elevations in the levels of these parameters typify hepatocellular injury. 48 Therefore, the observed elevations in the levels of these parameters in EFV-treated rats indicate hepatocellular injury. In various forms of liver disease, serum levels of numerous cytosolic, mitochondrial and membrane associated enzymes are increased. The detailed mechanism by which enzymes released from the cytosol and mitochondria of hepatocytes into the blood stream is not completely known. Clinical observations and experimental studies have shown that subtle membrane changes are sufficient to allow passage of intracellular enzymes to the intracellular space. 49 A very large concentration gradient between the hepatocytes and the sinusoidal space usually exists for enzymes. Cell damage increases membrane permeability, causing cytosolic iso-enzymes to spill into the sinusoids and from there into the peripheral blood. 50 Oxidative stress has been considered as a pathological mechanism that characterises the initiation and progression of drug-induced liver injury. A network of antioxidant defence which include SOD, GAT and GSH is structured in the liver of mammals for cellular response to down-regulate oxidative stress under physiological condition and to maintain redox homeostasis in the liver. 51 However, the stimulatory production of excessive free radicals from oxygen and nitrogen could alter liver redox homeostasis leading to antioxidant depletions. [51] [52] [53] Hence, the observed decreases in the liver levels of SOD, CAT, GSH and GPX in EFV-treated rats are evidence of hepatic oxidative stress. Oxidative stress can cause hepatic damage by inducing antioxidants depletion, irretrievable alteration of lipids, proteins and DNA contents and more importantly, modulates pathways that control normal hepatic biological functions. 54, 55 MDA has been widely used for many years as a convenient biomarker for lipid peroxidation which is a free-radical-mediated chain of reactions. Its level is always elevated in a state of established oxidative stress and lipid peroxidation. 6, 57 Therefore, the observed elevated liver levels of MDA in EFV-treated rats suggest lipid peroxidation which Furthermore, in the present study pretreatment with NAC, vitamins C and E ameliorate EFV-induced hepatic damage. More so, ameliorative effects were most observed in rats pretreated with combined doses of vitamins C and E than their individual doses. The hepatoprotective effects of antioxidants observed in the present study correlate with findings by Ebuehi et al (2012) 58 who reported the palliative effects of vitamins C and E on lead-induced hepatotoxicity in rats. Similarly Awodele and co-researchers reported the ameliorative effects of vitamins C and E on nevirapine-induced hepatotoxicity in rats. 59 Also, Naglaa et al., 2015 60 reported the beneficial effect of NAC on acetaminophen-induced hepatotoxicity in rats.
In the current study, these antioxidants might have protected the liver by inhibiting the chain reactions of EFV-generated free radicals or scavenged the free radicals before they reached their hepatic targets. Also, these antioxidants might have inhibited the depletion of endogenous antioxidants or facilitate their regeneration. NAC is a direct and indirect antioxidant that scavenges, neutralizes and chelates free radicals, thereby inhibiting oxidative destruction of tissues and organs. 61 It can maintain -SH groups of enzymes and membrane proteins in their reduced state. 62 NAC can reduce extracellular cystine to cysteine, or produce SH required for the synthesis of hepatic GSH. It can prevent drug-induced hepatic GSH depletion as well; up-regulate the activity of hepatic GSH. Also, NAC can enhance hepatic glutathione-S-transferase, SOD, and CAT activities, and promote detoxification mechanisms. 63 Vitamin C is a water soluble antioxidant that scavenges free radicals in extracellular fluid, trapping radicals and protecting biological membrane from oxidative damage. 64 It is an important source of electrons and it easily donates electrons to free radicals such as hydroxyl radicals and super oxide radicals, thereby down-regulating their activities. 65 Also, vitamin C can up-regulate the levels and activities of some endogenous antioxidants. 66 Vitamin E is an essential lipophilic antioxidant that can inhibit oxidative radical-induced damage to polyunsaturated fatty acids and act as a membrane-stabilizing agent that can prevent damage to phospholipids. 67 It is mainly found in the hydrocarbon part of membrane lipid bilayer towards the membrane interface and in close proximity to oxidise enzymes which can initiate the production of free radicals. 68, 69 Studies have shown that it can inhibit peroxidation of membrane lipids by scavenging lipid peroxyl radicals, as a consequence of which it is converted into a tocopheroxyl radical a potent antioxidant. 70 Also, it can prevent xenobiotic-induced hepatic mitochondria oxidative stress by down-regulating the activities of oxidative radicals. 71 In conclusion, the present study gives an insight on the possible use of antioxidants as recipes for efavirenz-induced liver toxicity in rats.
